Integration of Tobacco Treatment Services into Cancer Care at Stanford

As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was e...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of environmental research and public health Vol. 17; no. 6; p. 2101
Main Authors Gali, Kathleen, Pike, Brittany, Kendra, Matthew S, Tran, Cindy, Fielding-Singh, Priya, Jimenez, Kayla, Mirkin, Rachelle, Prochaska, Judith J
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 22.03.2020
MDPI
Subjects
Addictions
Behavior modification
Cancer
Cancer therapies
Chronic obstructive pulmonary disease
Clinics
Drug stores
Medical diagnosis
Oncology
Patients
Pharmacy
Quality
Quality control
Smoking
Telemedicine
Tobacco
Palo Alto California
United States > US
California
cancer care
tobacco treatment
smoking cessation
quality improvement
oncology
Online AccessGet full text

Cover

More Information
Summary:As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was engaged first in January 2019 as a pilot site given staff receptivity, elevated smoking prevalence, and a high tobacco screening rate (95%) yet low levels of tobacco cessation treatment referrals (<10%) and patient engagement (<1% of smokers treated). To improve referrals and engagement, system changes included an automated "opt-out" referral process and provision of tobacco cessation treatment as a covered benefit with flexible delivery options that included phone and telemedicine. Screening rates increased to 99%, referrals to 100%, 74% of patients were reached by counselors, and 33% of those reached engaged in treatment. Patient-reported abstinence from all tobacco products at 6-month follow-up is 20%. In July 2019, two additional oncology clinics were added. In December 2019, less than one year from initiating the QI pilot, with demonstrated feasibility, acceptability, and efficacy, the tobacco treatment services were integrated into 14 clinics at Stanford Cancer Center.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph17062101